Navigation Links
Genzyme Announces Presentation of New Positive Data on Carticel(R)
Date:3/10/2008

st cell therapy to be approved by the FDA. First introduced in March of 1995, Carticel received accelerated approval from the FDA in August of 1997 after the FDA instituted specific cell therapy guidelines. Under accelerated approval, the FDA required Genzyme to conduct confirmatory post-marketing clinical studies. Genzyme successfully completed the confirmatory studies and, in June of 2007, the FDA deemed the commitment satisfied.

To learn more about Carticel please visit http://www.carticel.com.

Cell Therapy Expertise at Genzyme

Genzyme has more than a decade of experience in developing and manufacturing autologous cell therapy products that have been used to treat thousands of patients. Epicel(R) (cultured epidermal autografts), a cell therapy for treating patients with severe burns, is also manufactured by Genzyme. Together, Carticel and Epicel represent the first such products ever brought to market in the United States, providing Genzyme with superior scientific and commercial expertise in this field.

About Carticel

CARTICEL is for autologous use and is indicated for the repair of symptomatic cartilage defects of the femoral condyle (medial, lateral or trochlea), caused by acute or repetitive trauma, in patients who have had an inadequate response to a prior arthroscopic or other surgical repair procedure (e.g., debridement, microfracture, drilling/abrasion arthroplasty, or osteochondral allograft/autograft). CARTICEL should only be used in conjunction with debridement, placement of a periosteal flap and rehabilitation. The independent contributions of the autologous cultured chondrocytes and other components of the therapy to outcome are unknown. It is not indicated for the treatment of cartilage damage associated with generalized osteoarthritis. It is not recommended for patients whose knee meniscus has been surgically removed unless the patient has undergone surgical reco
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
2. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
3. Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML
4. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ALPHARETTA, Ga. , July 6, 2015  EndoChoice ... release its second quarter 2015 financial results on Thursday, ... EndoChoice will hold a conference call on Thursday, ... the results. The dial-in numbers are (866) 807-9684 for ... live webcast of the conference call will be available ...
(Date:7/6/2015)... July 6, 2015  OrthoSpace Ltd. ("OrthoSpace" or ... three patients in its US Investigational Device Exemption ... patient randomized, single blinded control study that compares ... repair or partial repair for the treatment of ... is currently commercially available outside of ...
(Date:7/6/2015)... , July 6, 2015 /CNW/ - The Canadian Pharmacists ... national immunization strategy to ensure that all Canadians have ... of HPV (human papillomavirus) through immunization. The lack of ... Canada is needlessly putting the ... diseases, such as HPV, continue to pose a significant ...
Breaking Medicine Technology:EndoChoice to Report Second Quarter 2015 Financial Results on August 6, 2015 2OrthoSpace Enrolls First Patients in US IDE Study 2CPhA Calls for HPV Strategy for Young Men to Save Lives 2
... 2011  Generex Biotechnology Corporation (OTCBB: GNBT.OB) today announced ... Express breast cancer vaccine did not air yesterday ... December 16, 2011 promotional spot).  The Company will ... Television advise as to a rescheduled air date ...
... 2011 The in Thought™ research ... leading provider of scientific information and analytics, today ... cardiology pipeline that gives cardiologists and their patients ... in Thought,s Leon Henderson, "Innovative Medicine Shaping ...
Cached Medicine Technology:Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment 2Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment 3inThought Report Says New Wave of Cardiology Drugs to Be Big Boon 2inThought Report Says New Wave of Cardiology Drugs to Be Big Boon 3inThought Report Says New Wave of Cardiology Drugs to Be Big Boon 4
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... For ... finding medical providers for personal injury victims. Throughout the company’s history the goal ... deliver the care victims need in their recovery. And while Doctors on Liens ...
(Date:7/6/2015)... ... July 06, 2015 , ... Respected southern California personal injury attorney Fernando ... him as an attorney who has sharp legal skills as well as a superior ... for 2015 from Martindale-Hubbell and a Top 10 Award from The National Academy of ...
(Date:7/6/2015)... ... , ... University of Pittsburgh Cancer Institute (UPCI) scientists recently led ... newly available tests that better incorporate personalized medicine into diagnosing the condition. , ... is published in the July issue of the scientific journal Thyroid . ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... Shortly ... on Liens , the leading network of doctors working on a lien basis. ... Doctors on Liens. , The daughter of two Cambodian refugees, Dr. Lim suffered with ...
(Date:7/6/2015)... Beach, Virginia (PRWEB) , ... July 06, 2015 ... ... States choose fat-reduction procedures each year for aesthetic reasons, which is why liposuction ... country. For a particular demographic, however, fat reduction has become more than a ...
Breaking Medicine News(10 mins):Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3
... FAIRFAX, Va., Oct. 24 Kathleen M. Foley, ... City, and Perry Fine,MD, of the University of ... in Education and Leadership Award for 2007 at ... The award recognizes,contributors to the advancement of palliative ...
... improved efficacy and reduced toxicity, studies find, , , WEDNESDAY, ... chemotherapy drug, docetaxel, to the standard two-drug regimen used ... the treatment while reducing the toxicity, two new studies ... effective that it increased survival in both studies and ...
... Norway October 24, 2007 - The use of ... increased incidence of reproductive endocrine disorders in both men ... the effects of withdrawal from two common AEDs, carbamazepine ... and female AED users. , The study finds ...
... New research results from the University at Buffalos Research ... aware of and accurately evaluate the extent of their ... use., Researchers also found that in cases where parents ... twice as likely to underestimate frequency of marijuana use ...
... by needles, experts say , , WEDNESDAY, Oct. 24 (HealthDay ... can be given the nasal spray influenza vaccine FluMist, ... only recommended for healthy people ages 5 to 49. ... than 5, but the advisers said Wednesday that FluMist ...
... to Leverage Zagat,s, Expertise to Survey Physicians; WellPoint Members ... Rate Experiences Using Zagat,s Renowned 30-Point ... WellPoint, Inc., the,nation,s largest health benefits company, and Zagat ... online survey tool that will allow,consumers to share their ...
Cached Medicine News:Health News:Two Physicians Recognized for Work in Pain and Symptom Management 2Health News:Three Chemo Drugs Better Than Two for Advanced Head/Neck Cancers 2Health News:Three Chemo Drugs Better Than Two for Advanced Head/Neck Cancers 3Health News:Gauging parent knowledge about teens' substance use 2Health News:Gauging parent knowledge about teens' substance use 3Health News:U.S. Advisers OK Nasal Spray Flu Vaccine for Young Children 2Health News:U.S. Advisers OK Nasal Spray Flu Vaccine for Young Children 3Health News:WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 2Health News:WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: